Connor, Clark & Lunn Investment Management (CC&L)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,500	Closed	-$211K	–	632
2014 Q4	$211K	Buy	+17,500	New	+$200K	﹤0.01%	521
2013 Q4	–	Sell	-18,100	Closed	-$268K	–	777
2013 Q3	$268K	Buy	18,100 +4,100	+29%	+$62.8K	﹤0.01%	434
2013 Q2	$222K	Buy	+14,000	New	+$185K	﹤0.01%	462

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MNTA Position: Q1 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2015, closing a stake of 17,500 shares — an estimated $211K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MNTA in Q2 2013 and held it in 3 quarters. The position peaked at $268K in Q3 2013. 143 funds tracked by Wall St. Rank hold MNTA as of Q1 2015.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 17,500 Momenta Pharmaceuticals, Inc. shares in Q1 2015, an estimated $211K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Momenta Pharmaceuticals, Inc. position peaked at $268K in Q3 2013.
143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2015, filed 14 May 2015.